PRE ESS RELEA ASE

PREESS RELEA
ASE
ARD
DIAN ARRA
ANGES €92M
€
UNIITRANCHEE FINANC
CING
FOR IMV
V TECHNO
OLOGIES
Paris, Decemberr 15th, 2014: Ardian, the premium
m independeent private investment company,
€
unitrannche financiing to suppo
ort the acquuisition of
announcces today thhat it has arranged a €92m
IMV Technologies by Qualium
m Investisseement. IMV produces and distribuutes equipm
ment and
consuma
ables for annimal reprod
duction bioteechnology. This financinng includes a €12m accquisition
line.
Founded
d in 1963, IMV
I
Techno
ologies enjoyys internatio
onal recognittion mainly tthanks to its status of
pioneer of the anim
mal artificial insemination. It is the only
o player to
t offer a fuull range of products
for 14 animal
a
speciies. In 2014
4, the company will achhieve around
d €68m turnnover of whhich 80%
is generrated outsidee of France thanks to itts network of
o sellers covvering moree than 120 countries
c
and its 5 subsidiariees in the USA
A, India, China, Italy annd the Netheerlands.
The Privvate Debt activity
a
of Ardian had already
a
arranged a mezzanine financing in October
2010 to
o support thhe acquisitio
on of IMV by
b Pragma Capital.
C
Since then, IM
MV Technolo
ogies has
experiennced a solid growth notably
n
thro
ough its targ
geted acquisition strateegy. During the last
couple of
o years, the company has compleeted 7 acquuisitions inclluding the b
build-up on Polysem,
specializzing in single use veterinary protecction (Francee), that Ardiian Private D
Debt has also partly
financed
d via a new mezzanine financing inn February 2012.
2
Guillaum
me Chinardet, Managiing Directorr Private Deebt at Ardia
an said: “W
We are delighted to
continuee supporting
g IMV in its developmeent strategy. Its track reecord, its prroduct diverrsification
coverage have
and its geographic
g
h
allowed IMV to beecome a wo
orld leading
g player of its sector.
Our fina
ancing will provide IM
MV with thee flexibility needed to pursue its expansion strategy,
notably via build-up
ps.”
Jacquess Pancrazi, Managing
M
D
Director
at Qualium
Q
Invvestissementt, added: “W
We were veery much
attracted
d to IMV Technologies by its sense of entrepreeneurship annd the qualitty of its management
team. We
W are very happy to take part in thhe next step of the Group’s develop
pment and to
o support
its strateegy of targetted acquisitiions, innovation and inccrease of ma
arket shares,, mainly in emerging
e
countriees (Brasil, Chhina, India and
a Africa).””
Gilles de Robert dee Lafregeyree, President of the Boarrd of IMV Technologies
T
s, added: “TThis new
partnersship with Qualium Inveestissement will
w allow thhe Group to
o pursue its innovation strategy
and its internationall developmeent, mainly on
o fast growing markets like India and China.”
ABOUT ARDIAN
Ardian, founded in 1996 and led by Dominique Senequier, is a premium independent private
investment company with assets of US$50bn managed or advised in Europe, North America and
Asia. The company keeps entrepreneurship at its heart and delivers investment performance to its
global investors while fuelling growth in economies across the world. Ardian’s investment process
embodies three values: excellence, loyalty and entrepreneurship. Ardian’s employees form the
largest shareholder group. Over 80 percent of employees have invested in the company, which is
testament to their trust in the management and the corporate strategy.
Ardian maintains a truly global network, with more than 340 employees working through ten
offices in Paris, London, New York, Beijing, Frankfurt, Jersey, Luxembourg, Milan, Singapore and
Zurich. The company offers its 346 investors a diversified choice of funds covering the full range
of asset classes, including Fund of Funds (primary, early secondary and secondary), Direct Funds
including Infrastructure, Expansion, Mid Cap Buyout, Ardian Croissance, Co-Investment and
Private Debt.
www.ardian-investment.com
ABOUT IMV TECHNOLOGIES
Founded in 1963 and based in L'Aigle in the French region of Normandy, IMV Technologies is
the global leader in biotechnologies for animal artificial insemination. Recognized worldwide for
the quality of its products, the group’s development is based on the conception of new
technologies and expertise for artificial insemination techniques. With five foreign subsidiaries
(US, India, China, Italy and the Netherlands) and a network of distributors across more than 120
countries, IMV Technologies generates almost 80% of its revenue abroad and has around 450
employees.
More information: www.imv-technologies.com
ABOUT QUALIUM INVESTISSEMENT
Qualium Investissement is a subsidiary of the Caisse des Dépôts operating in the non-public sector
market. Authorized by the French Financial Markets Authority (AMF), it manages capital for thirdparty investors in France and other countries.
Specializing mainly in majority control buyouts, it invests amounts of between €20 million and
€100 million, mainly in French and European small and medium-sized companies valued from
€40 million to €250 million, and may share in control transactions of up to €500 million.
Founded in 1998, Qualium Investissement manages €1.2 billion in funds provided by its sponsor,
the Caisse des Dépôts, and over 40 third-party French and foreign subscribers. Since its creation,
it has invested in some 60 companies across a large spectrum of industries (manufacturing, agrofood, specialty retailing, engineering, etc.).
It currently has investments in 12 unlisted French companies, including Invicta, Quick, Kermel, Feu
Vert, Sogal, Mériguet and, more recently, Poult.
For more information: www.qualium-investissement.com
PRESS CONTACTS
Ardian
Headland
TOM JAMES
Tel: +44 207 3675240
Mobile: +44 7818 594 991
[email protected]

Download Report